Femivag vaginal capsules tube No. 10

Instructions for Femivag capsules vaginal tube No. 10

Composition

active ingredients: strains of live lactic acid bacteria Lactobacillus gasseri (L. gasseri), Lactobacillus rhamnosus (L. rhamnosus);

1 vaginal capsule contains at least 108 CFU of L. gasseri and at least 108 CFU of L. rhamnosus;

excipients: lactate monohydrate (E 966), corn starch, xanthan gum, anhydrous glucose, magnesium stearate, titanium dioxide (E 171), gelatin.

Dosage form

Vaginal capsules.

Main physicochemical properties: white gelatin capsules containing white or almost white powder with a faint characteristic odor and taste.

Pharmacotherapeutic group

Antimicrobial and antiseptic agents used in gynecology. Other antimicrobial and antiseptic agents. Lactobacillus fermentum.

ATX code G01A X14.

Pharmacological properties

Pharmacodynamics

Femivag vaginal capsules contain two strains of live lactic acid bacteria that usually dominate the vaginal microflora of healthy women: L. gasseri and L. rhamnosus.

Although the mode of action of vaginal lactic acid bacteria is still being studied, it has been shown to be multifactorial and associated with the action of many factors. Due to the enzymatic production of lactic acid, the lactic acid bacteria strains that dominate the vagina of healthy women maintain low pH values, which inhibit the colonization and growth of pathogenic microorganisms. In addition, due to their adhesive properties and the ability to produce hydrogen peroxide and bacteriocins, lactic acid bacteria counteract the invasion of unwanted microorganisms.

Indication

prevention and treatment of imbalance of vaginal bacterial flora, symptoms of which are itching, dryness, discharge, irritation, unpleasant odor; treatment of mild and moderate bacterial vaginosis; protection and restoration of the natural balance of vaginal microflora after treatment with antimicrobial agents.

Contraindication

The use of the drug is contraindicated in case of hypersensitivity to the active substances or to any other components of the drug.

Interaction with other medicinal products and other types of interactions

There is no information on interactions with other vaginal products.

No specific studies have been conducted on the interactions of Femivag with other drugs. However, since the lactic acid bacteria that make up the drug are sensitive to local and systemic antimicrobial agents, such combination therapy is not recommended.

Application features

If symptoms worsen or do not improve after a seven-day course of treatment, patients should consult a doctor. In case of relapses, it is also recommended to consult a doctor.

Ability to influence reaction speed when driving vehicles or other mechanisms

Does not affect.

Use during pregnancy or breastfeeding

Pregnancy

The drug Femivag can be used during pregnancy (for example, for the treatment of bacterial vaginosis in pregnant women).

Breast-feeding

Femivag can be used during breastfeeding.

Method of administration and doses

Treatment

1 vaginal capsule is inserted deep into the vagina every evening before bedtime for 6-8 days.

Prevention

Immediately after the end of menstruation: 1 vaginal capsule is inserted deep into the vagina every evening before bedtime for 4-6 days.

After antibiotic treatment: 1 vaginal capsule is inserted deep into the vagina every evening before bedtime for 6-8 days.

Children

The drug should not be used to treat children under 12 years of age.

Overdose

No information available.

Adverse reactions

There are isolated reports of allergic reactions associated with the use of the drug.

Expiration date

2 years.

Do not use after the expiry date stated on the packaging.

Storage conditions

Store in the original packaging at a temperature not exceeding 25 ºС.

Keep out of reach of children.

Packaging

10 vaginal capsules in an aluminum tube closed with a plastic lid with a desiccant.

1 tube in a cardboard box.

Vacation category

Without a prescription.

Producer

Bifodan A/S.

Location of the manufacturer and its business address

Bogbindervej 6, DK-3390 Hundested, Denmark.